201. Multilineage contribution of CD34 + cells in cardiac remodeling after ischemia/reperfusion injury.
- Author
-
Xie J, Jiang L, Wang J, Yin Y, Wang R, Du L, Chen T, Ni Z, Qiao S, Gong H, Xu B, and Xu Q
- Subjects
- Mice, Animals, Humans, Ventricular Remodeling, Heart, Antigens, CD34, Ischemia, Endothelial Cells, Reperfusion Injury
- Abstract
The ambiguous results of multiple CD34
+ cell-based therapeutic trials for patients with heart disease have halted the large-scale application of stem/progenitor cell treatment. This study aimed to delineate the biological functions of heterogenous CD34+ cell populations and investigate the net effect of CD34+ cell intervention on cardiac remodeling. We confirmed, by combining single-cell RNA sequencing on human and mouse ischemic hearts and an inducible Cd34 lineage-tracing mouse model, that Cd34+ cells mainly contributed to the commitment of mesenchymal cells, endothelial cells (ECs), and monocytes/macrophages during heart remodeling with distinct pathological functions. The Cd34+ -lineage-activated mesenchymal cells were responsible for cardiac fibrosis, while CD34+ Sca-1high was an active precursor and intercellular player that facilitated Cd34+ -lineage angiogenic EC-induced postinjury vessel development. We found through bone marrow transplantation that bone marrow-derived CD34+ cells only accounted for inflammatory response. We confirmed using a Cd34-CreERT2 ; R26-DTA mouse model that the depletion of Cd34+ cells could alleviate the severity of ventricular fibrosis after ischemia/reperfusion (I/R) injury with improved cardiac function. This study provided a transcriptional and cellular landscape of CD34+ cells in normal and ischemic hearts and illustrated that the heterogeneous population of Cd34+ cell-derived cells served as crucial contributors to cardiac remodeling and function after the I/R injury, with their capacity to generate diverse cellular lineages., (© 2023. The Author(s).)- Published
- 2023
- Full Text
- View/download PDF